Literature DB >> 17456997

Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide.

Takao Nakahara1, Yoshifumi Takata, Yoji Hirayama, Kihiro Asano, Hirotaka Adachi, Genzo Shiokawa, Teijin Sumi, Takashi Ogawa, Akira Yamashina.   

Abstract

BACKGROUND: The present study examined the role of aldosterone in left ventricular hypertrophy (LVH) and geometry in patients with untreated essential hypertension (EHT), and investigated the contribution of myocardial fibrosis to the process of LVH. METHODS AND
RESULTS: The relationship of the plasma aldosterone concentration (PAC) to LVH and left ventricular (LV) geometry was investigated in 57 consecutive patients with untreated EHT. PAC correlated with both LV mass index (LVMI: r=0.46, p=0.0004) and relative wall thickness (RWT: r=0.33, p=0.013). In patients with LVH (LVMI > or =125 g/m(2)), the serum concentration of procollagen type III amino-terminal peptide (PIIINP), a marker of myocardial fibrosis, correlated with RWT (r=0.46, p=0.029). These patients were divided into 2 groups: concentric hypertrophy (CH) with RWT > or =0.44, and eccentric hypertrophy (EH) with RWT <0.44. The serum PIIINP concentration was significantly higher in the CH group than in the EH group (0.52+/-0.02 ng/ml vs 0.44+/-0.03 ng/ml, respectively; p<0.05).
CONCLUSIONS: Aldosterone may be involved in LVH and LV geometry, particularly in the development of CH. Myocardial fibrosis seems more strongly involved in the hypertrophic geometry of CH than with EH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456997     DOI: 10.1253/circj.71.716

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  10 in total

1.  Serum concentration of procollagen type III amino-terminal peptide is increased in patients with successfully repaired coarctation of the aorta with left ventricular hypertrophy.

Authors:  Hirokuni Yamazawa; Tomoaki Murakami; Atsuhito Takeda; Kouta Takei; Takuo Furukawa; Hiromichi Nakajima
Journal:  Pediatr Cardiol       Date:  2014-10-14       Impact factor: 1.655

2.  Relationship of galectin-3 to left ventricular geometry and hypertrophy in chronic hemodialysis patients.

Authors:  H Yilmaz; O M Gurel; H T Celik; A Bozkurt; M E Yildirim; I Bilgic; M A Bilgic; N Bavbek; A Akcay
Journal:  Herz       Date:  2014-06-14       Impact factor: 1.443

Review 3.  Extracellular matrix fibrotic markers in heart failure.

Authors:  Faiez Zannad; Patrick Rossignol; Wafae Iraqi
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

4.  Hyperuricemia and its association with carotid intima-media thickness in hypertensive and non hypertensive patients.

Authors:  Abdelhakem Selem Elsayed; Mansour Mohamad Mostafa; Alshazly Abdelkhalik; Mohey Eldeen A Eldeeb; Mohammed Shafee Abdulgani
Journal:  J Saudi Heart Assoc       Date:  2010-03-10

5.  TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis.

Authors:  Siva S V P Sakamuri; Anthony J Valente; Jalahalli M Siddesha; Patrice Delafontaine; Ulrich Siebenlist; Jason D Gardner; Chandrasekar Bysani
Journal:  Mol Cell Endocrinol       Date:  2016-04-01       Impact factor: 4.102

6.  Relations of biomarkers representing distinct biological pathways to left ventricular geometry.

Authors:  Raghava S Velagaleti; Philimon Gona; Daniel Levy; Jayashri Aragam; Martin G Larson; Geoffrey H Tofler; Wolfgang Lieb; Thomas J Wang; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Circulation       Date:  2008-11-10       Impact factor: 29.690

7.  Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism.

Authors:  Marianne Aa Grytaas; Kjersti Sellevåg; Hrafnkell B Thordarson; Eystein S Husebye; Kristian Løvås; Terje H Larsen
Journal:  Endocr Connect       Date:  2018-02-12       Impact factor: 3.335

8.  The relationship between Aldosterone level and various LV conditions in patients with End-stage renal disease.

Authors:  Vida Nesarhosseini; Hossein Mohsenipouya; Atieh Makhlough; Rozita Jalalian
Journal:  Caspian J Intern Med       Date:  2019

9.  A Single Nucleotide Polymorphism near the CYP17A1 Gene Is Associated with Left Ventricular Mass in Hypertensive Patients under Pharmacotherapy.

Authors:  Matthias Huber; Susanne Lezius; Rona Reibis; Andras Treszl; Dorota Kujawinska; Stefanie Jakob; Karl Wegscheider; Heinz Völler; Reinhold Kreutz
Journal:  Int J Mol Sci       Date:  2015-07-30       Impact factor: 5.923

10.  Relationship between Plasma Aldosterone Levels and Left Ventricular Mass in Hypertensive Africans.

Authors:  Adewole Adebiyi; Olubayo Akinosun; Chibuike Nwafor; Ayodele Falase
Journal:  Int J Hypertens       Date:  2013-10-07       Impact factor: 2.420

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.